Effect of Calcium Supplements [calcium carbonate; Tums Ultra] on Nilotinib Hydrochloride [Tasigna] Pharmacokinetics in Healthy Volunteers (CAMN107DUS10T) (UPCI 08-077).
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2013
At a glance
- Drugs Nilotinib (Primary) ; Calcium carbonate
- Indications Chronic myeloid leukaemia; Gastrointestinal stromal tumours
- Focus Pharmacokinetics
- 17 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Apr 2011 Planned end date changed from 1 Aug 2010 to 1 Aug 2013 as reported by ClinicalTrials.gov.